Enhanced nitric oxide synthesis reverses salt-induced alterations in blood flow and cGMP levels

Clinical and Experimental Hypertension

Volumn 21, Issue 4, 1999, Pages 333-352

  Bayorh, Mohamed A ^a,b   Williams, E ^a   Thierry Palmer, M ^a   Sanford, G ^a   Emmett, N ^a   Harris Hooker, S ^a   Socci, R R ^a   Chu, T C ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b Dept of Pharmacology/Toxicology ^*  (United States)

Author keywords

Blood flow; Blood pressure; Cyclic GMP; Dahl rats; Eicosapentaenoic acid; L arginine; Salt sensitivity

Indexed keywords

ARGININE; CYCLIC GMP; ICOSAPENTAENOIC ACID; NITRIC OXIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA FLOW; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE REGULATION; HYPERTENSION; KIDNEY BLOOD FLOW; LIPID PEROXIDATION; NONHUMAN; PATHOPHYSIOLOGY; PHOSPHATE METABOLISM; RAT; SODIUM BALANCE;

EID: 0032964528     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969909068669     Document Type: Article

References (34)

1. Lüscher, T.F., Boulanger, C.M., Cohi, Y., Yang, Z. Endothelium-derived contracting factors. Hypertension 1992; 19: 117-130.
2. Nelson, M.T., Quayle, J.M. Physiological roles and properties of potassium channels in arterial smooth muscle. Amer. J. Physiol. 1995; 268: C799-C822.
3. 2+-signalling. Progr. Biophys. mol. Biol. 1996; 65: 265-296.
4. Bayorh, M.A., McGee, L., Feuerstein, G. Acute and chronic effects of eicosapentaenoic acid (EPA) on the cardiovascular system. Res. Commun. Chem. Pathol. Pharmacol. 1989; 66: 355-374.
5. 3H]nitrobenzylthioinosine binding sites. Clin. Exp. Hypertension 1996; 18: 37-49.
6. Burr, M. Fish food, fish oil and cardiovascular disease. Clin. Exper. Hypertension 1992; A14: 181-192.
7. Hoffman, P. Cardiovascular actions of dietary polyunsaturated fatty acids and related mechanisms: a state of the art review. Prostagl. Leukotr. Med. 1986; 21: 113-147.
8. Tobian, L. Salt and hypertension: Lessons from animal models that relate to human hypertension. Hypertension 1991; 17 (Suppl. I): I-52-I-60.
9. Dahl, L.K., Knudsen, K.D., Heine, M., Leitl, G. Effects of chronic excess salt ingestion. Genetic influence on the development of salt hypertension in parabiotic rats: evidence for a humoral factor. J. Exp. Med. 1967; 126: 687-699.
10. Dahl, L.K., Knudsen, K.D., Iwai, J. Humoral transmission of hypertension: Evidence from parabiosis. Circ. Res. 1969; 24-25 (Suppl. 1): 21-33.
11. Folkow, B., Ely, D.L. Editorial Review. Dietary sodium effects on cardiovascular and sympathetic neuroeffector function as studied in various rat models. J. Hypertension 1987; 5: 383-395.
12. Mark, A.L. Sympathetic neural contribution to salt-induced hypertension in Dahl rats. Hypertension 1991; 17 (Suppl. I): I-86-I-90.
13. Chen, P.Y., Sanders, P.W. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J. Clin. Invest. 1991; 88: 1559-1567.
14. Lüscher, T.F., Raij, L., VanHoutte, P.M. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl strain rats. Hypertension 1987; 9: 157-163.
15. Kong, J.-Q., Taylor, D.A., Fleming, W.W., Kotchen, T.A. Specific supersensitivity of the mesenteric vascular bed of Dahl salt-sensitive rats. Hypertension 1991; 17: 349-356.
16. Akiba, Y., Yamaguchi, N., Amano, H., Fujii, T., Fujimoto, K., Suzuki, T., Kawashima, K. Role of nitric oxide in the control of blood pressure in young and adult spontaneously hypertensive rats. Clin. Exper. Pharmacol. Physiol. 1995; 22 (Suppl. 1): S142-S143.
17. Rees, D.D., Palmer, R.M.J., Moncada, S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Nat'l. Acad. Sci. USA 1989; 86: 3375-3378.
18. Chu, T.C., Socci, R.R., Potter, D.E. Moxonidine-induced inhibition of norepinephrine release in monkey and rabbit ciliary bodies: Role of cGMP. Pharmacol. 1997; 55: 211-216.
19. Merkel, L. Zaprinast: A cGMP-selective phosphodiesterase inhibitor. Cardiovasc. Drug Rev. 1993; 11: 501-515.
20. Schmieder, R.E., Rüddel, H., Schächinger, H., Bruns, J., Schulte, W. Renal hemodynamics and cardiovascular reactivity in the prehypertensive stage. Behavioral Medicine 1993; 19: 5-12.
21. Saavendra, J.M., McCarty, R., Fernandez-Pardal, J., Giucheney, P., Weise, V., Iwai, J. Proceedings of Fourth International Symposium on Rats with Spontaneous Hypertension, Heidelberg, (Abstract) pp, 28; 1981.
22. Takeshita, A., Mark, A.L., Brody, M.J. Prevention of salt-induced hypertension in the Dahl strain by 6-hydroxydopamine. Amer. J. Physiol. 1979; 236: H48-H52.
23. Campese, V.M., Romoff, M.S., Levitan, J., Saglikes, Y., Fredier, R., Massry, S.G. Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Intl. 1982; 21: 371-378.
24. Deng, A.Y., Rapp, J.P. Locus for the inducible, but not a constitutive, nitric oxide synthase cosegregates with blood pressure in Dahl salt-sensitive rats. J. Clin. Invest. 1995; 95: 2170-2177.
25. Ferrario, C.M., Tramposch, A., Kawano, Y., Brosnihan, K.B. Sodium balance and the reflex regulation of baroreceptor function. Circulation 1987; 75 (Suppl. I): I-141-I-148.
26. Simchon, S., Manger, W.M., Carlin, R.D., Peeters, L.L., Rodriguez, J.R., Batista, D., Brown, T., Merchant, N.B., Jan, K.M., Brinberg, D.E., Chien, S. Salt-induced hypertension in Dahl salt-sensitive rats: hemodynamics and renal responses. Hypertension 1989; 13: 612-621.
27. Simchon, S., Manger, W.M., Brown, T.W. Dual hemodynamic mechanisms for salt-induced hypertension in salt-sensitive Dahl rats. Hypertension 1991; 17: 1063-1071.
28. Kumagai, K., Suzuki, H., Ichikawa, M., Jimbo, M., Murakami, M., Ryuzaki, M., Saruta, T. Nitric oxide increases renal blood flow by interacting with the sympathetic nervous system. Hypertension 1994; 24: 220-226.
29. G-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent presser agent in the guinea pig: does nitric oxide regulate the blood pressure in vivo? Biochem. Biophys. Res. Commun. 1989; 160: 881-886.
30. Calver, A., Collier, J., Vallance, P. L-arginine-induced hypotension. Lancet 1990; 336: 1016-1017.
31. Mimran, A., Ribstein, J., DuCailar, G. Contrasting effect of antihypertensive treatment on the renal response to l-arginine. Hypertension 1995; 26: 937-941.
32. Dundore, R.L., Clas, D.M., Wheeler, L.T., Habeeb, P.G., Bode, D.C., Buchholz, R.A., Silver, P.J., Pagani, E.D. Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats. Eur. J. Pharmacol. 1993; 249: 293-297.
33. Paul, R.V., Wackym, P.S., Warnock, D.G. Decreased cyclic GMP response to ANP in mesanglial cells from salt-sensitive (SS-JR) compared to salt-resistant (SR-JR) rats. Hypertension 1993; 22: 431. Abstract.
34. Ferri, C., Bellini, C., Piccoli, A., Carlomagno, A., Bonavita, M.S., Santucci, A., Balsano, F. Enhanced blood pressure response in cyclooxygenase inhibition in salt-sensitive human essential hypertension. Hypertension 1993; 21: 875-881.